🔎 Trials Near Me

Akèy › Timò Nèwo-endokrin

Etid klinik pou Timò Nèwo-endokrin ap rekrite nan Etazini

40 etid pou Timò Nèwo-endokrin ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Ap rekriteFaz 2
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06406465

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 24, 2026 · NCT05237934

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07087054

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07165132

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Aug 25, 2026 · NCT03206060

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT07151391

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07132645

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07129252

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT05263050

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Jul 13, 2026 · NCT05000294

Integrated Cancer Repository for Cancer Research

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

Ap rekriteVolontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Jun 10, 2026 · NCT06788886

CapTemY90 for Grade 2/3 NET Liver Metastases

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04339036

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Ap rekriteFaz 1/2
Laj 18 a 90 · Tout sèks · Mizajou May 14, 2026 · NCT05636618

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT04074135

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.